Inventor
SCOTT RICHARD W
US21 patents
⚠️ This page may combine multiple inventors who share the name “SCOTT RICHARD W”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CEPHALON INC
7 patentsUS5869336AFeb 9, 1999
Recombinant enzymatically active calpain expressed in a baculovirus system
CEPHALON INC168 citations97
US5521086AMay 28, 1996
Secretion sequence for the production of a heterologous protein in yeast
CEPHALON INC60 citations95
US6057143AMay 2, 2000
Recombinant enzymatically active calpain expressed in a baculovirus system
CEPHALON INC22 citations91
US5814300ASep 29, 1998
Gene-targeted non-human mammals deficient in the SOD-1 gene
CEPHALON INC48 citations89
US5777194AJul 7, 1998
Gene-targeted mice with humanized Aβ sequence and Swedish FAD mutation
CEPHALON INC16 citations70
US6734336B1May 11, 2004
Gene-targeted non-human mammal with human fad presenilin mutation and generational offspring
CEPHALON INC3 citations59
US6284944B1Sep 4, 2001
Gene-targeted non-human mammal with a human fad presenilin mutation and generational offspring
CEPHALON INC3 citations59
CELLCEUTIX CORP
6 patentsUS9795575B2Oct 24, 2017
Compounds for use in treatment of mucositis
CELLCEUTIX CORP5 citations82
US9457027B2Oct 4, 2016
Compounds for use in treatment of mucostis
CELLCEUTIX CORP6 citations82
US9155738B2Oct 13, 2015
Compounds for use in treatment of mucostitis
CELLCEUTIX CORP7 citations82
US10166232B2Jan 1, 2019
Arylamide compounds and compositions and uses thereof
CELLCEUTIX CORP3 citations72
US9469616B2Oct 18, 2016
Cyclic compounds and methods of making and using the same
CELLCEUTIX CORP5 citations69
US8895561B2Nov 25, 2014
Compounds and methods for treating candidiasis and aspergillus infections
CELLCEUTIX CORP4 citations66